solvay pharmaceutical – cardiometabolics, gastroenterology, women’s/men’s health, mental health and other products
Solvay Pharmaceuticals GmbH (Solvay) is a part of the Solvay Group, a leading chemical and pharmaceutical company headquartered in Brussels. It provides health care products and services based on its scientific, technical and commercial expertise. Solvay’s product portfolio can be broadly categorized into Cardiometabolics, Gastroenterology, Women’s/Men’s Health, Mental Health and other products. Solvay ranks among the top 40 pharmaceutical companies worldwide. Its business is focused on five therapeutic areas: Neuroscience, Cardiometabolic, Influenza vaccines, Gastroenterology, Women’s and Men’s Health. Solvay operates through a network of corporate offices located in Germany, The Netherlands and the US. Solvay is active in more than 40 countries, and its products are marketed in more than 150 countries
It manufactures active pharmaceutical ingredients at its plants located in The Netherlands, Germany, France and Canada. The company uses state-of-the-art equipment, and all manufacturing processes are at par with the “Good Manufacturing Practice” (GMP) regulations. Solvay’s global marketing strategies are tailored to local culture and standards by individual country managements. It uses geographic expansion as a main growth driver and aims to be present everywhere where its key products will be appreciated and used willingly by needy doctors and patients. Solvay aims at expanding its presence to Central and Eastern Europe, Australia, Africa, the Middle East, India and the Far East. Solvay conducts research and development in the Neuroscience, Cardiometabolic, Influenza vaccines and Pancreatic enzymes sectors. Solvay aims to develop innovative solutions to current medical problems. Reduction of development time is a priority, since time to market is essential to recoup the significant investments in R&D. Solvay’s major R&D centers are located in Europe (The Netherlands, Germany, France), US and Japan.
Cardiometabolics
Cardiometabolics are used for curing cardiovascular diseases. Drugs produced under this category include OMACOR®, PHYSIOTENS® and TEVETEN®.
Gastroenterology
Gastroenterology deals with drugs for curing gastrointestinal diseases such as irritable bowel syndrome, pancreatic exocrine insufficiency, inflammatory bowel disease, portal-systemic encephalopathy, and constipation. Drugs produced under this category include CREON®, DICETEL®, DUPHALAC® and DUSPATAL®.
Mental Health
Mental health deals with treatment of psychiatric and neurological disorders. Drugs produced under this category include DUODOPA® and LUVOX®.
Women’s/Men’s Health
In the women’s health category Solvay offers Hormone replacement therapy (HRT) for curing menopausal symptoms and complaints. DUPHASTON® is used to cure menstrual disorders, in HRT and threatened and habitual abortion. FEMOSTON® is used for oral HRT. In the men’s category Solvay produces AndroGel® for curing testosterone deficiency.
In addition, Solvay also produces drugs for the treatment of burns and infection, influenza vaccine INFLUVAC® and SERC®.
PROFILE TOOLS
OMACOR® is used in combination with other medicines, for treatment after a heart attack
Creon® is used for the treatment of pancreatic exocrine insufficiency, associated with various conditions, including cystic fibrosis, chronic pancreatitis and pancreatic surgery.
DUODOPA® is used for curing advanced progressive Parkinson's disease





